PharmaSGP Holding SE

XETRA PSG.DE

PharmaSGP Holding SE Market Capitalization on January 14, 2025: USD 318.80 M

PharmaSGP Holding SE Market Capitalization is USD 318.80 M on January 14, 2025, a 0.03% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • PharmaSGP Holding SE 52-week high Market Capitalization is USD 345.77 M on October 24, 2024, which is 8.46% above the current Market Capitalization.
  • PharmaSGP Holding SE 52-week low Market Capitalization is USD 259.87 M on September 10, 2024, which is -18.49% below the current Market Capitalization.
  • PharmaSGP Holding SE average Market Capitalization for the last 52 weeks is USD 299.72 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
XETRA: PSG.DE

PharmaSGP Holding SE

CEO Ms. Natalie Weigand
IPO Date June 19, 2020
Location Germany
Headquarters Lochhamer Schlag 21
Employees 89
Sector Health Care
Industries
Description

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Similar companies

SBS.DE

Stratec SE

USD 29.11

3.16%

AJ91.DE

DocCheck AG

USD 9.64

1.15%

OHB.DE

OHB SE

USD 49.68

-0.22%

DMP.DE

Dermapharm Holding SE

USD 41.22

0.60%

M7U.DE

Nynomic AG

USD 21.54

1.09%

StockViz Staff

January 15, 2025

Any question? Send us an email